Beverly Hills eye specialist Edgar Thomas swabbed his patient’s eye with anesthetic and reached for a syringe. “Now hold very still for me,” he told Cecilia Blackfield, as he inserted the needle into ...
LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...
Once again, eye doctors have successfully lobbied to keep their Avastin. Medicare will abandon its new, lower reimbursement level for the cancer drug when used by eye doctors to treat wet macular ...
Reda A. Mahdy, MD; Waled M. Nada, MD; Khaled M. Fawzy, MD; Haitham Y. Alnashar, MD; Salah M. Almosalamy, MD The failure rate at 18 months' follows-up was 5% (P < 0.01) in the Avastin group and 50% (P ...
In a good news/bad news development for Roche, a U.K. trial offers hard evidence that the company's cancer treatment Avastin is an effective treatment for wet macular degeneration. That's the good ...
ZURICH/LONDON (Reuters) - Roche , trying to get back on its feet after a dismal year, could soon face a new blow if its top cancer drug Avastin proves to be a viable cut-price alternative to Lucentis ...
Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly ...
I read the article by Shah and Shah 1 with great interest. I congratulate the authors for evaluating the effects of early single intravitreal injection of bevacizumab followed by panretinal and ...
At least 16 people in two states have gotten severe eye infections, and some have been blinded, from injections of the drug Avastin, according to health authorities and to lawyers representing the ...
The Senate has set up an ad hoc committee to investigate the case of blindness caused by the use of Avastin injection at the National Eye Centre, Kaduna. According to a resolution of the Senate on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results